Large endometrial polyp with sarcomatous stromal components following long-term tamoxifen treatment for breast cancer: A case report and review of the literature

European Journal of Gynaecological Oncology

Volumn 24, Issue 6, 2003, Pages 565-568

  Varras, M ^a,d   Akrivis, Ch ^b,c  

^a KAT HOSPITAL   (Greece)

^b G HATZIKOSTA GENERAL HOSPITAL   (Greece)

^c District National Health System   (Greece)

^d NONE   (Greece)

Author keywords

Mesenchymal tumours; Polyp; Sarcoma; Tamoxifen; Uterus

Indexed keywords

CARBOPLATIN; PACLITAXEL; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

AGED; ANAMNESIS; ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CURETTAGE; DISEASE COURSE; ENDOMETRIUM; ENDOMETRIUM POLYP; ENDOMETRIUM SARCOMA; ENDOMETRIUM TUMOR; FEMALE; GYNECOLOGIC SURGERY; GYNECOLOGICAL EXAMINATION; HUMAN; IMMUNOHISTOCHEMISTRY; LONG TERM EXPOSURE; MIXED MULLERIAN TUMOR; PATHOLOGY; PATIENT; POLYP; POSTOPERATIVE PERIOD; TREATMENT OUTCOME; UTERINE CERVIX DILATATION; VAGINA BLEEDING;

AGED; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIXED TUMOR, MULLERIAN; POLYPS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SURVIVORS; TAMOXIFEN;

EID: 0344876025     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Early Breast Cancer Trialists' Collaboration Group: "Tamoxifen for early breast cancer: an overview of the randomized trials". Lancet, 1998, 351, 1451.
2. Jordan V.C.: "Tamoxifen: Breast Cancer Update: Antiestrogens: Past, present, and future. A roundtable discussion". Zeneca Pharmacuticals, 1996.
3. Schlesinger C., Silverberg S.G.: "Tamoxifen-associated polyps (basalomas) arising in multiple endometriotic foci: A case report and review of the literature". Gynecol. Oncol., 1999, 73, 305.
4. Fisher B., Dignam J., Wilmark N., DeCellis A., Emir B., Wickerman L. et al.: "Tamoxifen and chemotherapy for lymph node negative, estrogen receptor positive breast cancer". J. Natl. Cancer Inst., 1996, 88, 1529.
5. Seoud M., Shamseddine A., Khalil A., Salem Z., Saghir N., Bikhazi K. et al.: "Tamoxifen and endometrial pathologies: a prospective study". Gynecol. Oncol., 1999, 75, 15.
6. Love R.R.: "Tamoxifen prophylaxis in breast cancer". Oncology, 1992, 6, 33.
7. Love R.R.: "Tamoxifen therapy in primary breast cancer: biology, efficacy and side effects". J. Clin. Oncol., 1989, 7, 803.
8. Killachey M.A., Hakes T.B., Pierce V.K.: "Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens". Cancer Treat. Rep., 1985, 69, 237.
9. Varras M., Polyzos D., Akrivis Ch.: "Effects of tamoxifen on the human female genital tract: review of the literature". Eur J. Gynaecol. Oncol., 2003, 24, 258.
10. De Muylder X., Neven P., De Somer M., Van Belle Y., Vanderick G., De Muylder E.: "Endometrial lesions in patient undergoing tamoxifen therapy". Int. J. Gynecol. Obstet., 1991, 36, 127.
11. Bocklage T., Lee K.R., Belinson J.L.: "Uterine Müllerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy". Gynecol. Oncol., 1992, 44, 104.
12. Treilleux I., Mignotte H., Clement-Chassagne C., Guastalla P., Bailly C.: "Tamoxifen and malignant epithelial-nonepithelial tumors of the endometrium: report of six cases and review of the literature". Eur. J. Surg. Oncol., 1999, 25, 477.
13. Fotiou S., Hatjieleftheriou G., Kyrousis G., Kokka F., Apostolakis N.: "Long-term tamoxifen treatment: a possible aetiological factor in the development of uterine carcinosarcoma: Two case-reports and review of the literature". Anticancer Research, 2000, 20, 2015.
14. Pautier P., Genestie C., Ray A., Morice Ph., Roche B., Lhommé C. et al.: "Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma". Cancer, 2000, 88, 1425.
15. Clement P.B., Scully R.E.: "Müllerian adenosarcoma of the uterus: A clinicopathological analysis of ten cases of a distinctive type of Müllerian mixed tumor". Cancer, 1974, 34, 1138.
16. th ed., Kurman R.J. (ed.), New York, Springer-Verlag, 1987, 487.
17. Carvalho F.M., Carvalho J.P., da Motta V., Souen J.: "Mü llerian adenosarcoma of the uterus with sarcomatous overgrowth following tamoxifen treatment for breast cancer". Rev. Hosp. Clin. Fac. Med. S. Paulo, 2000, 55, 17.
18. Arici D.S., Aker H., Yildiz E., Tasyurt A.: "Mullerian adenosarcoma of the uterus associated with tamoxifen therapy". Arch. Gynecol. Obstet., 2000, 264, 105.
19. Clement P.B., Scully R.E.: "Mullerian adenosarcoma of the uterus - A clinicopathologic analysis of 100 cases with a review of the literature". Hum. Pathol., 1990, 21, 363.
20. Oda Y., Nakanishi I., Tatewa T.: "Intramural Mullerian adenosarcoma of the uterus with adenomyosis". Arch. Pathol. Lab. Med., 1984, 108, 798.
21. Gal D., Kerner H., Beck D., Peretz A., Eyal A., Paldi E.: "Case reports: Mullerian adenosarcoma of the cervix". Gynecol. Oncol., 1988, 31, 445.
22. Kerner H., Lichtig C., Beck D.: "Extrauterine Mullerian adenosarcoma of the peritoneal mesothelium - A clinicopathologic and electron microscopic study". Obstet. Gynecol., 1989, 73, 510.
23. Buckley C.H., Fox H.: "Miscellaneous benign conditions of the endometrium". In: "Biopsy Pathology of the Endometrium". Buckley C.H., Fox H. (eds.), London, Chapman and Hall, 1989, 131.
24. Ramodetta L.M., Sherwood J.B., Dunton C.J., Palazzo J.P.: "Endometrial cancer in polyps associated with tamoxifen use". Am. J. Obstet. Gynecol., 1999, 180, 340.
25. Lahti E., Blanco G., Kanppila A., Apaja-Sarkkinen M., Taskinen P.J., Laatikainen T.: "Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen". Obstet. Gynecol., 1993, 81, 660.
26. Beral V.: "Prevention of cancers of the female genital tract". In: The Biology of Gynaecological Cancer. Leake R., Gore M., Ward R.H. (eds.), London, RCOG Press, 1995, 217.
27. Adami H.-O., Krusemo U.B., Bergkvist L., Persson I., Pettersson B.: "On the age-dependent association between cancer of the breast and the endometrium. A nationwide cohort study". Br. J. Cancer, 1987, 55, 77.
28. Stears V., Gelmann E.P.: "Does tamoxifen cause cancer in humans?". J. Clin. Oncol., 1998, 16, 779.
29. Tosi P., Sforza V., Santopietro R.: "Estrogen receptor content, immunohystochemically determined by monoclonal antibodies in endometrial stromal sarcoma". Obstet: Gynecol., 1989, 73, 75.
30. nd ed., 1996, 217.
31. Varras M., Spandidos D.A.: "Molecular biology of gynaecological cancer". In: Gynecological Oncology (in Greek). Pektasidis D., Demopoulos M-A. (eds.). Athens, Medical publications Paschalidis P., 2001, 68.
32. Varras M.N., Zachos G., Spandidos D.A.: "Endometrial carcinoma in a breast cancer patient treated with tamoxifen: Activation of K-ras proto-oncogene". Oncol. Rep., 1997, 4, 1045.